Filing Details

Accession Number:
0001140361-15-024569
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-17 15:58:15
Reporting Period:
2015-06-15
Filing Date:
2015-06-17
Accepted Time:
2015-06-17 15:58:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514588 Adam Havey 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Evp, Biodefense Divison No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-15 15,919 $14.67 57,363 No 4 M Direct
Common Stock Disposition 2015-06-15 15,919 $31.50 41,444 No 4 S Direct
Common Stock Acquisiton 2015-06-15 9,773 $15.83 51,217 No 4 M Direct
Common Stock Disposition 2015-06-15 9,773 $31.67 41,444 No 4 S Direct
Common Stock Disposition 2015-06-15 10,606 $31.50 30,838 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2015-06-15 15,919 $0.00 15,919 $14.67
Common Stock Stock Option Disposition 2015-06-15 9,773 $0.00 9,773 $15.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,960 2010-03-11 No 4 M Direct
0 2019-03-12 No 4 M Direct
Footnotes
  1. Consists of an option granted under the company's stock incentive plan on March 12, 2013.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.055 to $31.77, inclusive.
  4. Consists of an option granted under the company's stock incentive plan on March 13, 2012.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $31.72, inclusive.
  6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.03 to $31.76, inclusive.
  7. The option vested in three equal installments in March 2014, 2015 and 2016
  8. The option vested in three equal installments in March 2013, 2014 and 2015.